Skip to content

The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance

The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04146961
Enrollment
59
Registered
2019-10-31
Start date
2019-10-05
Completion date
2020-07-21
Last updated
2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract Surgery

Brief summary

Prospective survey study of patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric intraocular lens in both eyes.

Detailed description

This will be an open-label, prospective survey study of patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric intraocular lens in both eyes, comparing to an existing historical dataset of patient reported outcomes with bilateral ReSTOR 3.0 implants.

Interventions

DEVICEAlcon PanOptix or PanOptix Toric IOL

Patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric IOL in both eyes.

Sponsors

Research Insight LLC
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Patients implanted with the PanOptix or Panoptix Toric lenses bilaterally within 6 months of the survey administration. Patients may have the toric version of this lens in neither eye, one eye, or both eyes. * Patients with otherwise healthy eyes, not exhibiting any significant ocular morbidity that would be expected to influence outcome measures. * Patients whose spherical equivalent outcome is within 0.5D of target and whose magnitude of manifest postoperative cylinder is less than or equal to 0.75 diopters.

Exclusion criteria

* Patients with visually significant co-morbidities (corneal, retina, optic nerve disease) that could affect their satisfaction with surgery. * Patients with surgical complications either during or after surgery (capsule tears, iris trauma, decentered intraocular lens, cystoid macular edema, etc.) * Patients with greater than grade 1 posterior capsule opacity. * Patient sin the historical reference set who underwent Astigmatic Keratotomy or Limbal Relaxing Incision during cataract surgery. -

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction, measured as the percentage of patients reporting top box satisfaction6/1/20 - 7/1/20Primary objective: to determine the percentage of patients who report top box (5 out of 5) overall satisfaction on the questionnaire instrument. To determine the percentage of patients who report satisfaction (satisfied or very satisfied as 4 out of 5 on the attached questionnaire instrument.

Secondary

MeasureTime frameDescription
Percentage of postoperative patients who report overall satisfaction as either satisfied or very satisfied.6/1/20 - 7/1/20To report spectacle independence, measured as the percentage of patients who do not require glasses for each of the common activities queried like driving, reading, computer work, watching TV, and sports/hobbies. To determine the incidence of glare and halos described by the patient as a fair amount or worse (Question 20).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026